生物活性 | |||
---|---|---|---|
描述 | Acoziborole (SCYX-7158) is identified as a potent, safe, and orally administrable antiprotozoal compound, which holds promise for the study and potential treatment of Human African Trypanosomiasis (HAT). Specifically against the Trypanosoma brucei brucei S427 strain, SCYX-7158 exhibits a minimal inhibitory concentration (MIC) value of 0.6 µg/mL, highlighting its effectiveness against this parasitic disease[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.72mL 0.54mL 0.27mL |
13.62mL 2.72mL 1.36mL |
27.24mL 5.45mL 2.72mL |
参考文献 |
---|